Interest in psychedelics, such as psilocybin and LSD, is growing, with some locations easing criminal bans. Robert Mikos of Vanderbilt Law School discusses the challenges of legalising psychedelics federally. He highlights obstacles of rescheduling, congressional legislation, and constitutional challenges. He suggests states may offer an alternative pathway, despite potential federal crackdowns and limitations.
Read the full story here
Written by:
Published on May 3, 2024 at 05:26AM
Source: Medications News – Medicine News, Health News, Medications News, Medicines, Prescriptions, Medicical Science (opens in new tab)